Britain will be facing a bill of more than £15bn a year to diagnose and treat cancer in ten years time, new research has suggested.
The £5.9bn increase will hit the NHS, private and voluntary sectors hard as Britain's population continues to age and may result in falling survival rates. According to Bupa's Cancer Diagnosis and Treatment: A 2021 Projection report, the average cost of treating a cancer patient is set to hit £40,000, up from the current £30,000. At present, the national Institute for Health and Clinical Excellence (Nice) which decides whether drugs and procedures should be made generally available on the NHS does not recommend treatments which cost more than £20,000 to £30,000 per quality-adjusted li...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes